Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Neurourology and Urodynamics|December 11, 2019
Are there different patterns of detrusor overactivity which are clinically relevant? ICI-RS 2018Jerzy B Gajewski, Andrew Gammie, John Speich, et al.
Neurourology and Urodynamics|October 22, 2025
Phenotyping Overactive Bladder - Part 2: Can Management be Improved by Phenotyping, and Targeting Therapy According to Urgency Type and Other Characteristics? ICI-RS 2025Michel Wyndaele, Michael Samarinas, Apostolos Apostolidis, et al.
European Urology|October 12, 2010
Sacral neuromodulation for neurogenic lower urinary tract dysfunction: systematic review and meta-analysisThomas M Kessler, David La Framboise, Sven Trelle, et al.
European Urology|October 1, 2008
Recommendations on the use of botulinum toxin in the treatment of lower urinary tract disorders and pelvic floor dysfunctions: a European consensus reportApostolos Apostolidis, Prokar Dasgupta, Pierre Denys, et al.
Neurourology and Urodynamics|November 18, 2017
An International Continence Society (ICS) report on the terminology for adult neurogenic lower urinary tract dysfunction (ANLUTD)Jerzy B Gajewski, Brigitte Schurch, Rizwan Hamid, et al.
BJU International|January 25, 2006
Distribution of neuropeptide Y-containing nerves in the neurogenic and non-neurogenic detrusorAxel Haferkamp, Thomas Freund, Nina Wagener, et al.
Neurourology and Urodynamics|July 27, 2017
Long-term outcomes and risks factors for failure of intradetrusor onabotulinumtoxin A injections for the treatment of refractory neurogenic detrusor overactivityCharles Joussain, Mélanie Popoff, Véronique Phé, et al.
The Journal of Urology|June 11, 2005
Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month studyBrigitte Schurch, Marianne de Sèze, Pierre Denys, et al.
Neurourology and Urodynamics|May 18, 2019
Alpha-blockers for treating neurogenic lower urinary tract dysfunction in patients with multiple sclerosis: A systematic review and meta-analysis. A report from the Neuro-Urology Promotion Committee of the International Continence Society (ICS)Marc P Schneider, Jure Tornic, Radek Sýkora, et al.
European Urology|March 26, 2004
European experience of 200 cases treated with botulinum-A toxin injections into the detrusor muscle for urinary incontinence due to neurogenic detrusor overactivityAndré Reitz, Manfred Stöhrer, Guus Kramer, et al.
Pageof 8